From Casetext: Smarter Legal Research

Enriquez v. Nabriva Therapeutics PLC

United States District Court, S.D. New York
May 23, 2022
19 Civ. 4183 (VM) (S.D.N.Y. May. 23, 2022)

Opinion

19 Civ. 4183 (VM)

05-23-2022

LARRY ENRIQUEZ, Individually and On Behalf of All Others Similarly Situated, Plaintiff, v. NABRIVA THERAPEUTICS PLC, TED SCHROEDER, GARY SENDER, and JENNIFER SCHRANZ, Defendants.


CLASS ACTION

JURY TRIAL DEMANDED

ORDER GRANTING LETTER MOTION FOR AN ORDER APPROVING DISTRIBUTION OF CLASS SETTLEMENT FUND

Victor Marrero, U.S.D.J.

Whereas, this Court preliminarily approved the terms of the Stipulation of Settlement (the “Stipulation”) by Order dated January 28, 2021 (ECF No. 73) and approved the Plan of Allocation by Order dated May 14, 2021 (ECF No. 78);

Whereas, this Court retained jurisdiction over this Action for the purpose of supervising the implementation of the Stipulation and distribution of the Net Settlement Fund;

Whereas, this Court has reviewed the Letter Motion seeking distribution of the Net Settlement Fund by Lead Plaintiff Jonathan Schaeffer (“Plaintiff”), the Declaration of Eric Nordskog on Behalf of A.B. Data, Ltd. in Support of Plaintiff's Motion for Authorization to Distribute Net Settlement Fund (the “Nordskog Declaration”) submitted herewith, related documents, and good cause having been shown;

AND NOW, this 23 day of May 2022, upon consideration of Plaintiff's Motion, it is hereby ORDERED:

1. That Plaintiff's Motion is GRANTED;

2. The administrative determinations of the Settlement Administrator to accept the claims listed in Exhibits D & E to the Nordskog Declaration and described in ¶¶31-32 of the Nordskog Declaration, including claims submitted after the filing deadline but before April 19, 2022, are approved and those claims are accepted;

3. The administrative determinations of the Settlement Administrator to reject the claims listed in Exhibit F to the Nordskog Declaration and described in ¶33 of the Nordskog Declaration are approved and those claims are rejected;

4. No Proof of Claim received by the Settlement Administrator after April 19, 2022 may be accepted for processing;

5. The Settlement Administrator is authorized to make the distributions described in Plaintiff's Motion and the Nordskog Declaration;

6. Any balance remaining in the Net Settlement Fund nine (9) months after the initial distribution (whether by reason of tax refunds, uncashed checks or otherwise), shall, if feasible, be reallocated among Authorized Claimants in an equitable and economic fashion. These redistributions shall be repeated until the balance remaining in the Net Settlement Fund is no longer economically reasonable, in Plaintiff's Counsel's discretion, to distribute to Authorized Claimants;

7. At such time as Plaintiff's Counsel, in consultation with the Settlement Administrator, determines that further distribution of the funds remaining in the Net Settlement Fund to Authorized Claimants is not cost-effective, if funds remain after payment of any unpaid administration fees or expenses, taxes and tax preparation costs, and escrow fees, Plaintiff's Counsel shall propose a plan to the Court regarding the use of such funds for contribution to non-sectarian, not-for-profit organization(s);

8. The Settlement Administrator shall continue to receive, review and process any correspondence or information submitted by claimants with respect to already-filed Proofs of Claim. Should there be any adjustments to any Proofs of Claim prior to distribution of the Net Settlement Fund, the Settlement Administrator shall update its claims database with the new information and report the updated total to Plaintiff's Counsel prior to distribution;

9. All persons who were involved in the review, verification, calculation, tabulation, or any other aspect of the administration of claims filed in this Action, and all persons who were involved in the administration or taxation of the Net Settlement Fund, are released from liability for any and all claims arising out of such activities; and

10. This Court shall retain jurisdiction over any further application or matter which may arise in connection with this Action.

IT IS SO ORDERED


Summaries of

Enriquez v. Nabriva Therapeutics PLC

United States District Court, S.D. New York
May 23, 2022
19 Civ. 4183 (VM) (S.D.N.Y. May. 23, 2022)
Case details for

Enriquez v. Nabriva Therapeutics PLC

Case Details

Full title:LARRY ENRIQUEZ, Individually and On Behalf of All Others Similarly…

Court:United States District Court, S.D. New York

Date published: May 23, 2022

Citations

19 Civ. 4183 (VM) (S.D.N.Y. May. 23, 2022)